Provided by Tiger Fintech (Singapore) Pte. Ltd.

Checkpoint Therapeutics, Inc.

4.04
+0.0000
Post-market: 4.050.0100+0.25%18:01 EDT
Volume:1.11M
Turnover:4.48M
Market Cap:247.95M
PE:-2.85
High:4.06
Open:4.02
Low:4.02
Close:4.04
Loading ...

Checkpoint Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
31 Mar

Checkpoint Therapeutics Full Year 2024 Earnings: US$1.42 loss per share (vs US$1.87 loss in FY 2023)

Simply Wall St.
·
29 Mar

Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Press Release: Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

Dow Jones
·
28 Mar

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Dow Jones
·
21 Mar

Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
18 Mar

BUZZ-India's Sun Pharma set for best week in nearly 6 months after Checkpoint deal

Reuters
·
13 Mar

BUZZ-Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say

Reuters
·
11 Mar

Checkpoint Therapeutics Cut to Hold From Buy by Lake Street

Dow Jones
·
11 Mar

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires Live
·
11 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Reuters
·
11 Mar

Correction to Checkpoint Therapeutics Headline

Dow Jones
·
10 Mar

Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target

MT Newswires Live
·
10 Mar

Checkpoint Therapeutics jumps after deal to be acquired by Sun Pharma

TIPRANKS
·
10 Mar

India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details

Benzinga
·
10 Mar

Nasdaq Dips Over 3%; Checkpoint Therapeutics Shares Jump

Benzinga
·
10 Mar